Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fendo.2018.00169 http://scihub22266oqcxt.onion/10.3389/fendo.2018.00169 C5913278!5913278!29719529     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Endocrinol+(Lausanne) 2018 ; 9 (ä): ä Nephropedia Template TP {{tp|p=29719529|t=2018. ANGPTL8: An Important Regulator in Metabolic Disorders |pdf=|usr=}}{{29719529}} gab.com Text ANGPTL8: An Important Regulator in Metabolic Disorders JO: Front Endocrinol (Lausanne) http://www.kidney.de/pget.php?&tw=1&pmid=29719529 #FOAvip Long-term controversy regarding the role of angiopoietin-like protein 8 (ANGPTL8) in beta-cell proliferation and diabetes progression made it a research spotlight. Recently, the controversy was resolved. Although ANGPTL8 could not control beta-cell expansion and islet function, ANGPTL8 was still considered as a novel but atypical member in the ANGPTL family because of its unique structure and crucial effects on lipid metabolism. Besides, ANGPTL8 also participated in some other disorders such as non-alcoholic fatty liver disease and renal dysfunction. Understanding the features of ANGPTL8 may offer new diagnostic and therapeutic approaches to metabolic-related diseases. Therefore, we reviewed most recent findings about ANGPTL8 and aimed to provide an integrated picture of ANGPTL8. Twit Text FOAVip ANGPTL8: An Important Regulator in Metabolic Disorders ????Front Endocrinol (Lausanne) http://www.kidney.de/pget.php?&tw=1&pmid=29719529 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29719529 #FOAvip English Wikipedia <ref>{{Cite pmid|29719529}}</ref> ANGPTL8: An Important Regulator in Metabolic Disorders #MMPMID29719529 Luo M; Peng D Front Endocrinol (Lausanne) 2018[]; 9 (ä): ä PMID29719529show ga Long-term controversy regarding the role of angiopoietin-like protein 8 (ANGPTL8) in beta-cell proliferation and diabetes progression made it a research spotlight. Recently, the controversy was resolved. Although ANGPTL8 could not control beta-cell expansion and islet function, ANGPTL8 was still considered as a novel but atypical member in the ANGPTL family because of its unique structure and crucial effects on lipid metabolism. Besides, ANGPTL8 also participated in some other disorders such as non-alcoholic fatty liver disease and renal dysfunction. Understanding the features of ANGPTL8 may offer new diagnostic and therapeutic approaches to metabolic-related diseases. Therefore, we reviewed most recent findings about ANGPTL8 and aimed to provide an integrated picture of ANGPTL8. äANGPTL8: An Important Regulator in Metabolic Disorders (epmc).pdf DeepDyve Pubget Overpricing